ANTI-OBESITY AGENTS
Clinical trials for ANTI-OBESITY AGENTS explained in plain language.
Never miss a new study
Get alerted when new ANTI-OBESITY AGENTS trials appear
Sign up with your email to follow new studies for ANTI-OBESITY AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug boost weight loss after teen bariatric surgery?
Disease control Recruiting nowThis study looks at what happens to the body after bariatric surgery in people aged 12 to 24. It also tests whether adding semaglutide (a weekly injection) can help those who haven't lost enough weight 1 to 2 years after surgery. The goal is to understand why some respond better …
Matched conditions: ANTI-OBESITY AGENTS
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Your DNA may determine how well Weight-Loss drugs work
Knowledge-focused Recruiting nowThis study looks at whether a person's genetic makeup can predict how much weight they will lose on the drugs semaglutide or tirzepatide. Researchers will follow 220 adults with obesity who are starting one of these medications for six months. By analyzing genetic risk scores and…
Matched conditions: ANTI-OBESITY AGENTS
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC